SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-008916
Filing Date
2018-06-19
Accepted
2018-06-19 15:21:40
Documents
53
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 829547
2 ex31-1.htm EX-31.1 11528
3 ex31-2.htm EX-31.2 11081
4 ex32-1.htm EX-32.1 7764
5 ex32-2.htm EX-32.2 7248
  Complete submission text file 0001493152-18-008916.txt   4261149

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE obmp-20180331.xml EX-101.INS 587888
7 XBRL SCHEMA FILE obmp-20180331.xsd EX-101.SCH 47305
8 XBRL CALCULATION FILE obmp-20180331_cal.xml EX-101.CAL 54102
9 XBRL DEFINITION FILE obmp-20180331_def.xml EX-101.DEF 194647
10 XBRL LABEL FILE obmp-20180331_lab.xml EX-101.LAB 370205
11 XBRL PRESENTATION FILE obmp-20180331_pre.xml EX-101.PRE 285217
Mailing Address 11441 INDUSTRIPLEX BLVD SUITE 190 BATON ROUGE LA 70809
Business Address 11441 INDUSTRIPLEX BLVD SUITE 190 BATON ROUGE LA 70809 225-227-2384
OncBioMune Pharmaceuticals, Inc (Filer) CIK: 0001362703 (see all company filings)

IRS No.: 202590810 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52218 | Film No.: 18907022
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences